None of them is on the 503A bulks list or in Category 1 [2]. We found no FDA warning letter to PeRx as of Oct 24, 2026 [9].
PeRx is a US telehealth service, run as Wellness MD Group PC DBA PeRx, that prescribes compounded peptides and compounded GLP-1s after an online consultation [1].
Our verdict
AvoidPrescription-only and clear that its products are not FDA-approved, but most of its peptide menu cannot be legally compounded today. We do not link to it.
What checks out
- FDA record
- No warning letter found in FDA's database or in web searches of fda.gov, Oct 24, 2026.
- BBB
- Not checked. bbb.org blocks automated access.
- Best for
- No one, while it sells peptides that cannot be legally compounded.
Is PeRx legit?
PeRx exists and operates as a prescriber, not a research-chemical shop. Its site says prescriptions are issued only after an online consultation with an independent licensed provider, and it does not use "research use" labels [1]. It says compounded medications are not FDA-approved and that FDA does not review them for safety or effectiveness [4]. The footer names the company as Wellness MD Group PC DBA PeRx; we found no street address on the pages we read [4].
A prescription does not make a product legal to compound. Most of PeRx's menu sits outside FDA's Category 1 and the 503A bulks list [1] [2]. Under our rating rule, a live problem on the site today moves a company to Avoid, and we treat selling peptides that cannot be lawfully compounded that way. Our peptide FDA status tracker has the full status of each one.
PeRx's peptide menu, by legal status
| On PeRx's menu | Legal to compound today? | Why | Sources |
|---|---|---|---|
| BPC-157 (injectable and capsules), BPC/TB-500 | No | Not on the bulks list or in Category 1; July 2026 committee votes are not binding and FDA has not acted | [1] [2] [11] [6] |
| CJC-1295 / ipamorelin, tesamorelin / ipamorelin | No | The committee voted against CJC-1295 in December 2024; ipamorelin is not on the bulks list | [1] [12] [2] |
| Thymosin alpha-1 | No | The committee voted against it in December 2024 | [1] [12] |
| MOTS-c, epitalon, Semax | No | Favorable but nonbinding July 2026 votes; FDA has not acted | [1] [11] [13] |
| Selank (in Semax/Selank and a three-peptide blend) | No | Listed by FDA as nominated but withdrawn, which does not allow compounding | [1] [5] |
| DSIP | No | The committee voted against it on July 24, 2026 | [1] [13] |
| KLOW | No | A blend reported to contain GHK-Cu, BPC-157, TB-500 and KPV, none legal to compound for injection; see our KLOW page | [1] [2] |
| GHK-Cu (form not stated on the menu) | Injectable: no. Cream or other non-injectable: yes | Non-injectable forms are in Category 1; injectable GHK-Cu may not be compounded | [1] [2] |
| NAD+, glutathione | Yes, with a prescription | Category 1 | [1] [2] |
| Sermorelin, PT-141, SS-31 | Not confirmed | We found no clear FDA statement either way | [1] |
No interim policy is in force yet
An HHS and FDA "Interim Access Policy for Compounding Using Certain Peptides" was sent for White House review in mid-October 2026 and has not been issued; its text is not public [6] [7]. Review meetings are scheduled for Oct 21 to Oct 28, 2026 [8]. Committee votes and the pending policy do not, on their own, allow compounding [7].
What PeRx costs
| Product | Price | Billing | Source |
|---|---|---|---|
| Compounded semaglutide | $249 a month | Renews every 28 days until you cancel; no minimum | [3] |
| Compounded tirzepatide | $399 a month | Renews every 28 days until you cancel; no minimum | [3] |
| Peptide protocols | From $199 | Described as per prescription with no auto-renewal, and also as $199 to $349 a month on the same page | [3] |
Prices for peptides that can be legally prescribed are on our legal peptide price tracker. GLP-1 options are compared on tirzepatide online.
FDA, BBB and LegitScript check
- FDA warning letters: none to PeRx or Wellness MD Group in FDA's database or fda.gov search results, Oct 24, 2026 [9]. FDA's Aug 24, 2026 peptide letters went to research-peptide sellers, not PeRx [10]. See our FDA warning letter tracker.
- BBB: not checked. bbb.org blocks automated access.
- LegitScript: not checked. Its lookup needs an interactive form.
- Trustpilot: we could not load a PeRx profile.
Legal options instead
There is no legal way to buy BPC-157, TB-500 or thymosin alpha-1 for human use in the US today; our BPC-157 page explains the rules. For compounded GLP-1s, the company below is rated Clean. Our review list has the rest.
We earn commissions from some partners, which can affect where they appear on this page. It never changes a verdict. How we make money
Clean-rated alternatives for compounded GLP-1s
- Clean
Good fit for: low-price compounded GLP-1s
PriceSee our bmiMD review- What you get
- Compounded GLP-1 programs
- FDA record
- No live warning letter in our review
- BBB
- F; BBB cites 6 unanswered complaints out of 43, Oct 24, 2026 [14]
Visit bmiMDon the bmiMD website
- Clean
Good fit for: visits and medication in one price
PriceSee our Henry Meds review- What you get
- Visits and medication in one price
- FDA record
- No live warning letter in our review
- BBB
- F; BBB cites 31 unanswered complaints out of 236, mostly billing, cancellation and fulfillment, Oct 24, 2026 [15]
Visit Henry Medson the Henry Meds website
- Clean
Good fit for: compounded, brand and non-GLP-1 options
PriceSee our Found review- What you get
- Compounded semaglutide and tirzepatide, brand GLP-1s and non-GLP-1 options
- FDA record
- No warning letter found in our review
- BBB
- See review
Visit Foundon the Found website
Questions people ask
Is PeRx legit?
How much does PeRx cost?
PeRx lists compounded semaglutide at $249 a month and compounded tirzepatide at $399 a month, renewing every 28 days, and peptide protocols from $199, checked Oct 24, 2026 [3].
Does PeRx require a prescription?
Yes. PeRx says prescriptions are issued only after an online consultation with an independent licensed provider [1].
Does PeRx have an FDA warning letter?
We found none. FDA's warning letter database and fda.gov search showed no letter to PeRx or Wellness MD Group as of Oct 24, 2026 [9].
Is PeRx's BPC-157 legal?
Who owns PeRx?
The footer of PeRx's site names the company as Wellness MD Group PC DBA PeRx [4].
Medical review: pending. A licensed clinician has not yet reviewed this page.
Sources
15 cited
- PeRx home page and peptide menu. PeRx (Wellness MD Group PC), Oct 24, 2026.
- Bulk drug substances nominated for use in compounding under section 503A (categories document). FDA, May 14, 2026.
- PeRx pricing. PeRx, Oct 24, 2026.
- BPC-157. PeRx, Oct 24, 2026.
- Certain bulk drug substances for use in compounding that may present significant safety risks. FDA, Apr 22, 2026.
- Peptides at a crossroads: what wellness providers need to know. Holland & Knight, Oct 16, 2026.
- FDA submits interim peptide compounding policy for White House review: what pharmacies should know. Buchanan Ingersoll & Rooney, Oct 16, 2026.
- EO 12866 meetings: Interim Access Policy for Compounding Using Certain Peptides (RIN 0910-ZD94). Office of Information and Regulatory Affairs (reginfo.gov), Oct 24, 2026.
- Warning letters database. FDA, Oct 24, 2026.
- FDA balances peptide policy with enforcement against unlawful peptide sellers. Sheppard Mullin (FDA Law Update), Sep 18, 2026.
- Bulk list bound: PCAC backs majority of peptides in two-day public meeting. McDermott Will & Emery, Jul 27, 2026.
- PCAC final summary minutes, Dec 4, 2024. FDA, Dec 4, 2024.
- The peptide wave rolls on: PCAC adds two more bulk drug substances for the 503A list. Hyman, Phelps & McNamara (FDA Law Blog), Jul 24, 2026.
- bmiMD (MEDCCM, Inc.) business profile. Better Business Bureau, Oct 24, 2026.
- Henry Meds business profile. Better Business Bureau, Oct 24, 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.
